ARTICLE | Clinical News
GW Pharma, Otsuka Pharmaceutical preclinical data
September 24, 2012 7:00 AM UTC
In mice, >=50 mg/kg CBDV significantly reduced maximal electroshock-induced seizures and >=100 mg/kg CBDV significantly reduced audiogenic-induced seizures. In rats, >=100 mg/kg CBDV significantly red...